The 2017 results from the National Institute on Drug Abuse and University of Michigan’s annual drug abuse survey were released today showing that the percentage of teens using OTC cough medicine containing DXM to get high remains at just three percent, the lowest level recorded since 2015.
CHPA applauds Representative Lynn Jenkins on her recent introduction of H.R. 4618 which will provide two years of tax relief for millions of consumers by allowing them, once again, to use their existing HSAs and FSAs to purchase OTC medicines.
CHPA submitted comments this week to the Food and Drug Administration regarding the proposed development of an authorized list of dietary ingredients marketed prior to the Dietary Supplement Health and Education Act.
New members of the Consumer Healthcare Products Association (CHPA) Board of Directors were elected at the association’s fall meeting, held November 16, 2017, in New York City, N.Y.
The dietary supplement industry’s leading trade associations and the U.S. Anti-Doping Agency today joined in support of FDA actions to protect consumers from body-building products containing Selective Androgen Receptor Modulators illegally marketed as dietary supplements.
Today, CHPA announced a new initiative to support retailers in states that have adopted laws prohibiting the sale of OTC medicines containing the cough suppressant dextromethorphan to minors. The announcement comes on the heels of Nevada’s enactment of a DXM age-restriction law last week.
CHPA applauds AHPA’s new guidelines on Good Agricultural and Collection Practices and Good Manufacturing Practices for Botanical Material, and acknowledges their importance in helping to ensure the production and supply of high-quality herbal raw materials.
CHPA strongly supports the OTC Monograph system as a balanced framework for regulating OTC medicines containing ingredients with a proven history of safe use.
The Consumer Healthcare Products Association (CHPA) Educational Foundation is pleased to announce that Mary Leonard is assuming the role of foundation director.
To combat teen abuse of over-the-counter (OTC) medicines containing the cough suppressant dextromethorphan (DXM), Oregon Governor Kate Brown today signed legislation prohibiting the sale of DXM-containing products to minors.
